SCHEMBL4250747

SCHEMBL4250747

NC1Cc2ccccc2N(CC(=O)N2CCOCC2)C1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
AADAT Q8N5Z0 2/20 0.49
GOT1 P17174 1/20 0.49
KYAT1 Q16773 1/20 0.49
KYAT3 Q6YP21 1/20 0.49
GAA P10253 4/20 0.48
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 3/20 0.48
TP53 P04637 1/20 0.48
MAPT P10636 1/20 0.48
THRB P10828 1/20 0.48
ALOX12 P18054 1/20 0.48
MAPK1 P28482 1/20 0.48
ATM Q13315 1/20 0.48
POLB P06746 2/20 0.46
HTT P42858 2/20 0.46
TSHR P16473 1/20 0.45
CHRM2 P08172 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4075145 0.89 CHRM2 (0.53) MEN1KMT2AAADATGOT1KYAT1
SCHEMBL4075043 0.89 CHRM2 (0.56) MEN1KMT2AAADATGOT1KYAT1
SCHEMBL4250746 0.86 MEN1 (0.53) SMN1; SMN2MEN1KMT2AGAAALDH1A1
SCHEMBL4066762 0.86 PYGL (0.54) SMN1; SMN2MEN1KMT2AAADATGOT1
SCHEMBL4066626 0.86 AADAT (0.49) MEN1KMT2AAADATGOT1KYAT1
SCHEMBL4064775 0.83 PYGL (0.52) AADATGOT1KYAT1KYAT3ALDH1A1
SCHEMBL4069399 0.81 CHRM2 (0.48) MEN1KMT2AAADATGOT1KYAT1
SCHEMBL4073097 0.80 CHRM2 (0.51) MEN1KMT2AAADATGOT1KYAT1
SCHEMBL4072868 0.80 L3MBTL1 (0.46) SMN1; SMN2MEN1KMT2AAADATGOT1
SCHEMBL4891481 0.79 AADAT (0.59) AADATGOT1KYAT1KYAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099176-A1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PROSIDION LIMITED (GB) 2009-04-16 US disclosed
EP-1819332-B1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PROSIDION LTD (GB) 2009-03-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099176-A1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES PC, GOT2, PDK1 SMN1; SMN2 3651/4885MEN1 4007/4885KMT2A 2295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.